NS-2028 is commonly used in the study of nitric oxide (NO) signaling pathways; it completely inhibits NO-dependent relaxation in non-vascular smooth muscle (at 1 μM); it reduces vascular endothelial growth factor (VEGF)-induced angiogenesis and vascular permeability; it inhibits VEGF-induced endothelial cell migration by suppressing p38 MAPK activation; it decreases cell proliferation in human umbilical vein endothelial cells (HUVECs); and it significantly suppresses VEGF-induced neovascularization in vivo in a rabbit corneal angiogenesis model.